be7a011a4b99345234342df95dce87b8d414.pdf

Cost reduction the current high cost of drug

Info icon This preview shows pages 2–4. Sign up to view the full content.

Cost Reduction The current high cost of drug discovery and development is a major cause for concern among pharmaceutical companies [13]. Along with increasing productivity, pharmaceutical companies also aim to reduce the high failure rate in the drug discovery process so that increased number of drugs able to hit the market [14]. The high cost of various phases of clinical trials acts as limiting factors for number of drugs, which can be developed by pharmaceutical companies, and hence selecting the compounds with the best chances for approval is critical [15]. The costs of drug discovery and development generally include total costs from discovery to approval though some studies have included the costs of failed drugs and the costs for commercialization [13,16]. There is also a cost associated with the elongated process, beginning from discovery all the way to final approval [15,17]. Advances in bioinformatics accelerate drug discovery process, beginning with drug target identification and validation (viz., Docking), to assay development, and virtual-high-throughput screening (v- HTS)-all with the goal of identifying new potential chemical entities. Bioinformatics provides more efficient target discovery and validation approaches, thus help to ensure that more drug candidates are successful during the approval process and making it more cost-effective [3].
Image of page 2

Info icon This preview has intentionally blurred sections. Sign up to view the full version.

Open Access Journal of Pharmaceutical Research Reddy MA. Bioinformatics-Key to Drug Discovery and Development. J Pharm Res 2017, 1(5): 000126. Copyright© Reddy MA. 3 Figure 1: The role of bioinformatics in different stages of drug discovery process. Promote Novel Drug Development There are some collateral costs that bother the pharmaceutical industry [18]. These costs include commercialization costs, litigation and drug-recall costs, and general costs to society [17,19,20]. Commercialization costs for new drug to be about $250 million per approved drugs, are high mainly because most ‘‘new’’ drugs approved are essentially functional replicas of drugs that already exist [16,21]. Most of the copycat drugs are being commercialized to handle the illness for which there are drugs already; thus, there is a need of interface that can attract the attention of both physicians and patients who already have access to similar medication [22]. Bioinformatics can act as proper interface, and provides new approaches and opportunities to pharmaceutical companies to efficiently discover potential drug targets and develop novel drugs [2]. If drugs are not commercialized in competition with already existing equivalents, their commercialization costs are expected to fall significantly [23]. Barriers to Bioinformatics Progress in Drug Design Process Bioinformatics efforts did not make any impeccable changes in the drug discovery and development process.
Image of page 3
Image of page 4
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

What students are saying

  • Left Quote Icon

    As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

    Student Picture

    Kiran Temple University Fox School of Business ‘17, Course Hero Intern

  • Left Quote Icon

    I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

    Student Picture

    Dana University of Pennsylvania ‘17, Course Hero Intern

  • Left Quote Icon

    The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

    Student Picture

    Jill Tulane University ‘16, Course Hero Intern